EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. ACN
6. NVDA
7. IBM
8. PRIM
9. SPY
10. DPZ

Go back to EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 199.94 +0.23 (0.12%)
Previous Close $199.71    52 Week High $333.65 
Open $198.88    52 Week Low $223.02 
Day High $201.22    P/E 25.60 
Day Low $198.42    EPS $7.81 
Volume 366,874